Persistence of COVID-19 Symptoms after Recovery in Mexican Population
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19), a highly contagious infectious disease that has caused many deaths worldwide. Despite global efforts, it continues to cause great losses, and leaving multiple unknowns that we must resolve in order to face the pandemic more effectively. One of the questions that has arisen recently is what happens, after recovering from COVID-19. For this reason, the objective of this study is to identify the risk of presenting persistent symptoms in recovered from COVID-19. This case-control study was conducted in one state of Mexico. Initially the data were obtained from the participants, through a questionnaire about symptoms that they had at the moment of the interview. Initially were captured the collected data, to make a dataset. After the pre-processed using the R project tool to eliminate outliers or missing data. Obtained finally a total of 219 participants, 141 recovered and 78 controls. It was used confidence level of 90% and a margin of error of 7%. From results it was obtained that all symptoms have an associated risk in those recovered. The relative risk of the selected symptoms in the recovered patients goes from 3 to 22 times, being infinite for the case of dyspnea, due to the fact that there is no control that presents this symptom at the moment of the interview, followed by the nausea and the anosmia with a RR of 8.5. Therefore, public health strategies must be rethought, to treat or rehabilitate, avoiding chronic problems in patients recovered from COVID-19.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
International journal of environmental research and public health - 17(2020), 24 vom: 14. Dez. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Galván-Tejada, Carlos E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 23.12.2020 Date Revised 30.03.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3390/ijerph17249367 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM318927047 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM318927047 | ||
| 003 | DE-627 | ||
| 005 | 20240330234626.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/ijerph17249367 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1356.xml |
| 035 | |a (DE-627)NLM318927047 | ||
| 035 | |a (NLM)33327641 | ||
| 035 | |a (PII)E9367 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Galván-Tejada, Carlos E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Persistence of COVID-19 Symptoms after Recovery in Mexican Population |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.12.2020 | ||
| 500 | |a Date Revised 30.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19), a highly contagious infectious disease that has caused many deaths worldwide. Despite global efforts, it continues to cause great losses, and leaving multiple unknowns that we must resolve in order to face the pandemic more effectively. One of the questions that has arisen recently is what happens, after recovering from COVID-19. For this reason, the objective of this study is to identify the risk of presenting persistent symptoms in recovered from COVID-19. This case-control study was conducted in one state of Mexico. Initially the data were obtained from the participants, through a questionnaire about symptoms that they had at the moment of the interview. Initially were captured the collected data, to make a dataset. After the pre-processed using the R project tool to eliminate outliers or missing data. Obtained finally a total of 219 participants, 141 recovered and 78 controls. It was used confidence level of 90% and a margin of error of 7%. From results it was obtained that all symptoms have an associated risk in those recovered. The relative risk of the selected symptoms in the recovered patients goes from 3 to 22 times, being infinite for the case of dyspnea, due to the fact that there is no control that presents this symptom at the moment of the interview, followed by the nausea and the anosmia with a RR of 8.5. Therefore, public health strategies must be rethought, to treat or rehabilitate, avoiding chronic problems in patients recovered from COVID-19 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a persistent symptoms | |
| 650 | 4 | |a post-COVID syndrome | |
| 650 | 4 | |a recovered from COVID | |
| 700 | 1 | |a Herrera-García, Cintya Fabiola |e verfasserin |4 aut | |
| 700 | 1 | |a Godina-González, Susana |e verfasserin |4 aut | |
| 700 | 1 | |a Villagrana-Bañuelos, Karen E |e verfasserin |4 aut | |
| 700 | 1 | |a Amaro, Juan Daniel De Luna |e verfasserin |4 aut | |
| 700 | 1 | |a Herrera-García, Karla |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez-Quiñones, Carolina |e verfasserin |4 aut | |
| 700 | 1 | |a Zanella-Calzada, Laura A |e verfasserin |4 aut | |
| 700 | 1 | |a Ramírez-Barranco, Julio |e verfasserin |4 aut | |
| 700 | 1 | |a Avila, Jocelyn L Ruiz de |e verfasserin |4 aut | |
| 700 | 1 | |a Reyes-Escobedo, Fuensanta |e verfasserin |4 aut | |
| 700 | 1 | |a Celaya-Padilla, José M |e verfasserin |4 aut | |
| 700 | 1 | |a Galván-Tejada, Jorge I |e verfasserin |4 aut | |
| 700 | 1 | |a Gamboa-Rosales, Hamurabi |e verfasserin |4 aut | |
| 700 | 1 | |a Martínez-Acuña, Mónica |e verfasserin |4 aut | |
| 700 | 1 | |a Cervantes-Villagrana, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Rivas-Santiago, Bruno |e verfasserin |4 aut | |
| 700 | 1 | |a Gonzalez-Curiel, Irma E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of environmental research and public health |d 2004 |g 17(2020), 24 vom: 14. Dez. |w (DE-627)NLM162777434 |x 1660-4601 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2020 |g number:24 |g day:14 |g month:12 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/ijerph17249367 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2020 |e 24 |b 14 |c 12 | ||